Part of Medtronic Plc, Covidien Pte Ltd. is a Singaporean company located in Singapore that manufactures and supplies medical equipment.

Edwards Lifesciences Corp. engages in patient-focused medical innovations for heart disease and critical care monitoring. Its products are categorized into four main areas: Transcatheter Aortic Valve Replacement, Transcatheter Mitral and Tricuspid Therapies, Surgical Structural Heart, and Critical Care. It operates through the following geographical segments: United States, Europe, Japan, and Rest of World. The company was founded by Miles Lowell Edwards in 1958 and is headquartered in Irvine, CA.

Applied Medical Resources Corp. provides medical surgical devices. It offers products for cardiac and vascular surgery, general surgery, urology, colorectal surgery and OBGYN surgery devices. The firm's devices include abdominal access, endopyelotomy, endoureterotomy, hand access laparoscopy, graspers, wound retractor and ureteroscopy systems. The company was founded by Said S. Hilal in 1987 and is headquartered in Rancho Santa Margarita, CA.

Medtronic, Inc. operates as a medical technology company. It offers implantable cardiac pacemakers, eternal defibrillators, inferior turbinate surgery products, and continuous glucose monitoring device. The company was founded by Earl E. Bakken and Palmer J. Hermundslie on April 29, 1949 and is headquartered in Minneapolis, MN.

St. Jude Medical, Cardiology Division, Inc., a subsidiary of Abbott Laboratories, is a company headquartered in St. Paul, MN, that develops and commercializes minimally invasive cardiovascular and neurovascular medical devices. The firm was founded by Paul R. Buckman. Lisa D. Earnhardt is currently the CEO of the company.

Balance Medical manufactures biotechnology products. They produce soft tissue repair materials, heart valve replacements. The research, development, and production of medical devices derived from animal-derived implants. They conducts research and develops animal tissue engineering and original chemical modification treatment technology. The domestic technology research and development platform enterprise for animal-derived implantable interventional medical devices.

Cingular Biotech develops implantable and regenerative materials and devices. Cingular Biotech focuses on surgical valve replacement and repair with biomaterial technology, as well as transcatheter valves and other cardiovascular disease treatment fields.

FemRx, Inc., part of Johnson & Johnson, is a company headquartered in Sunnyvale, CA. The firm produces medical products for gynecological disorders. It was acquired by Johnson & Johnson on November 06, 1998 for $20.99 million.

Meditop Medical Technology is a provider of medical devices and solutions for cardiovascular diseases. They provide disease treatment solutions based on the etiology and condition. It also offers solutions to congenital heart disease, arrhythmia, and valve disease.

ICU Medical connects patients and caregivers through safe, life-saving, life-enhancing medical devices. They provide clinicians around the world with innovative and cost-effective patient care solutions for unmet clinical needs. Their products help clinicians improve patient outcomes by minimizing bacterial ingress that can cause bloodstream infections and preventing exposure to infectious diseases or hazardous drugs. Our diverse product line includes needlefree vascular access devices, custom infusion sets, closed system hazardous drug handling devices and systems, advanced sensor catheters, needlefree closed blood sampling systems, and innovative hemodynamic monitoring systems. These clinically-proven innovations are the result of a unique company culture, supported by visionary leaders and resourceful minds, united by the common desire to redefine the limits of patient and healthcare worker safety.

Part of Becton, Dickinson & Co., CareFusion 2200, Inc. is an American company located in San Diego, CA, focused on medical, dental, and hospital equipment and supplies.

Tendyne Holdings, Inc. is a clinical stage medical device company focused on the development of minimally invasive therapies for the treatment of mitral regurgitation. Mitral regurgitation is a condition that afflicts hundreds of thousands of individuals worldwide every year. Formed in 2010, their first product concept is a transcatheter mitral valve replacement prosthesis for the treatment of mitral regurgitation. The intent is for the valve to be deployed and secured with no disruption to the native mitral annulus while preserving the sub-valvular apparatus. Placement of the valve is intended to be completed transapically in a simple procedure where the implanting physician is able to re-position, remove, and re-deploy their valve throughout the procedure.

Ethicon Endo-Surgery, Inc. manufactures surgical devices and equipments. Its products include the ENDOPATH XCEL access system, CONTOUR curved cutter stapler, HARMONIC ultrasonic cutting and coagulation surgical devices and the MAMMOTOME breast biopsy system. The company was founded in 1992 and is headquartered in Cincinnati, OH.

H2Gen Innovations, Inc., of Alexandria , Virginia develops, manufactures and markets on-site hydrogen appliances that provide a significant breakthrough for the existing industrial hydrogen market and will be a key enabling technology for the emerging hydrogen economy. The H2Gen hydrogen generator module (HGM) converts natural gas to hydrogen using a unique steam methane reformer, producing 2,000 scf/hr. of up to “five nines” pure hydrogen. The all-in cost of hydrogen produced with the HGM at the point of delivery is 35% to 65% less than existing conventional methods of producing and delivering hydrogen to target end-use customers. They believe that they have the superior technology for on-site hydrogen production in regard to output, purity and price for a remarkably small appliance. The company was formed in February 2001 by a team of engineers who saw the market opportunity, and who had been working on the concept and technology for the preceding seven years.

Hollister, Inc. develops, manufactures and markets healthcare products and services. Its products include Ostomy, continence, wound, skin and critical care products. The company was founded by John Dickinson Schneider in 1921 and is headquartered in Libertyville, IL.

Wuhan Kaihe Tongli Medical Technology Co., Ltd., established on 2018-07-06, Business scope includes biotechnology development;Class II,Research and development of three types of medical devices,Sales;Information Technology Consulting Services;Laboratory Equipment Rental.(Projects subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Innoventric is a Structural Heart medical device company, mainly engaged in the development of percutaneous solutions for Tricuspid Regurgitation and right heart disease. Innoventric, a start-up company from Ness-Ziona, Israel, develops the unique Trillium™ technology for the treatment of Tricuspid Valve Regurgitation. The company was founded in 2017, and has rapidly progressed. Innoventric has performed over 10 implantations of the promising Trillium™ technology as part of its European first in human clinical trial. The company holds a broad patent portfolio for the Trillium™ and additional Tricuspid technologies.

Excision Medical, Inc. is an American company located in Malvern, PA. The firm manufactures medical devices. It was founded in 2020 by Greg A. Walters.\nThe company says this about itself: Excision Medical, Inc., is a privately held company focused on transforming the TAVR market though safe, simple, and reliable leaflet modification. The company was founded in 2020 by Greg Walters, former CEO of Essential Medical, Inc. (Teleflex, Inc.), Dr. Gary Roubin, MD, PhD, a coronary and carotid stenting pioneer, Dr. David Wood, MD, Head of Cardiology and Director of the Centre for Cardiovascular Innovation in Vancouver, British Columbia and Dr. Janarthanan Sathananthan, MD, MPH, Director of the Centre for Heart Valve Innovation Bench Testing Laboratory.

LSI Solutions, Inc. is an American private company. The firm manufactures and markets invasive surgical instruments.

Shanghai MicroPort CardioFlow Medtech Co., Ltd. (MicroPort CardioFlow), founded 2015 in the Shanghai Zhangjiang Hi-Tech Park, is a subsidiary of MicroPort Scientific Corporation MicroPort CardioFlow is dedicated to providing advanced minimally invasive therapies for structural heart diseases with its best-in-class capacities in R&D, manufacturing, marketing, and technical consulting services. We believe in “Focus, Innovation, and Globalization”, and in accordance, we place the utmost importance on saving and improving quality of life for patients. Consequently, we constantly strive to bring the most innovative valvular disease treatment solutions to patients while also operating on a global vision to provide all patients and physicians with world-leading products that are superior, reliable, yet affordable.